PP
NXTM

PDT Partners’s NxStage Medical Inc. NXTM Stock Holding History

PDT Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-21,800
Closed -$313K – 1725
2014
Q2 		$313K Buy
+21,800
New +$285K 0.01% 1184
2013
Q3 		– Sell
-36,094
Closed -$515K – 1822
2013
Q2 		$515K Buy
+36,094
New +$454K 0.01% 1048

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PDT Partners's NXTM Position: Q3 2014 in Review

PDT Partners sold out of NxStage Medical Inc. (NXTM) in Q3 2014, closing a stake of 21,800 shares — an estimated $313K sold.

PDT Partners first reported a position in NXTM in Q2 2013 and held it in 2 quarters. The position peaked at $515K in Q2 2013. 111 funds tracked by Wall St. Rank hold NXTM as of Q3 2014.

  • PDT Partners reported no remaining NxStage Medical Inc. position as of Q3 2014 after selling out during the quarter.
  • PDT Partners sold 21,800 NxStage Medical Inc. shares in Q3 2014, an estimated $313K.
  • PDT Partners first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 2 quarters.
  • PDT Partners's NxStage Medical Inc. position peaked at $515K in Q2 2013.
  • 111 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2014.

Based on PDT Partners's 13F filing for Q3 2014, filed 14 Nov 2014.